These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2405944)

  • 21. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tests of reversibility of bronchial obstruction].
    Meslier N; Racineux JL; Grandordy B
    Rev Mal Respir; 1986; 3(6):355-60. PubMed ID: 3575855
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day].
    Caputi M; Cautiero V; Aliberti M; Monici Preti PA; Oliani C
    Arch Monaldi Mal Torace; 1988; 43(5):409-21. PubMed ID: 3079283
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of ventilation changes in patients with obstructive bronchopneumopathy induced by bronchodilator drugs].
    De Benedetto F; Cervone M; De Blasio E; D'Ilario F; Fuciarelli R; Luciano A; Sborgia M
    Clin Ter; 1984 Jun; 109(6):509-17. PubMed ID: 6236941
    [No Abstract]   [Full Text] [Related]  

  • 25. Predicting response to bronchodilator therapy in chronic obstructive pulmonary disease.
    Pratter MR; Irwin RS
    Arch Intern Med; 1988 Sep; 148(9):1909-10. PubMed ID: 3415402
    [No Abstract]   [Full Text] [Related]  

  • 26. Some clinical problems in patients with airways obstruction.
    Turner-Warwick M
    Chest; 1982 Jul; 82(1 Suppl):3S-7S. PubMed ID: 7083948
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chronic obstructive lung diseases in patients with ischemic heart disease: a 15-year study].
    Kozlova LI; Buzunov RV; Chuchalin AG
    Ter Arkh; 2001; 73(3):27-32. PubMed ID: 11417176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of airways obstruction.
    Clark TJ
    Postgrad Med J; 1983; 59 Suppl 3():54-61. PubMed ID: 6359110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airways disease. Dutch CNSLD Study Group.
    Kerstjens HA; Brand PL; Quanjer PH; van der Bruggen-Bogaarts BA; Koëter GH; Postma DS
    Thorax; 1993 Jul; 48(7):722-9. PubMed ID: 8153921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Concomitant therapy with diagnostic respiratory function in the aged].
    Pleger E; Kämmer JC; Palowski H; Wendisch G
    Z Arztl Fortbild (Jena); 1990; 84(22):1153-6. PubMed ID: 2087811
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of salbutamol on pulmonary circulation, ventilation and gas exchange in patients with chronic obstructive airways disease. Preliminary report.
    Koziorowski A; Zielinski J; Maszczyk Z; Pawlicka L; Klimkiewicz H
    Bull Physiopathol Respir (Nancy); 1972; 8(3):611-6. PubMed ID: 4405131
    [No Abstract]   [Full Text] [Related]  

  • 33. Single versus multiple aerosol bronchodilator dosage in chronic obstructive pulmonary disease.
    Russakoff AH; Russakoff AD; Grimley KW
    Ala J Med Sci; 1974 Jul; 11(3):252-6. PubMed ID: 4451264
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacological Management of Elderly Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Room for Speculation?
    Castiglia D; Battaglia S; Benfante A; Sorino C; Scichilone N
    Drugs Aging; 2016 Jun; 33(6):375-85. PubMed ID: 27138954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of air pollution on symptoms and peak expiratory flow measurements in subjects with obstructive airways disease.
    Higgins BG; Francis HC; Yates CJ; Warburton CJ; Fletcher AM; Reid JA; Pickering CA; Woodcock AA
    Thorax; 1995 Feb; 50(2):149-55. PubMed ID: 7701453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness and tolerance of a combination of fluticasone and salmeterol in patients with obstructive airway diseases. DUO Study Group].
    Wiewrodt R; Dauletbaev N; Buhl R
    Pneumologie; 1998 Jan; 52(1):14-20. PubMed ID: 9540365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new bronchodilator, hexoprenaline, in obstructive pulmonary disease.
    van As A; Benjamin C; Stern JD
    Scand J Respir Dis; 1973; 54(1):28-37. PubMed ID: 4690403
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of short-term effect of rehabilitative therapy in chronic obstructive pulmonary disease.
    Ambrosino N; Paggiaro PL; Macchi M; Filieri M; Toma G; Lombardi FA; Del Cesta F; Parlanti A; Loi AM; Baschieri L
    Respiration; 1981; 41(1):40-4. PubMed ID: 7244391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs and the elderly. Precautions in using bronchodilators.
    Todd B
    Geriatr Nurs; 1984; 5(7):328-30. PubMed ID: 6565620
    [No Abstract]   [Full Text] [Related]  

  • 40. [Obstructive respiratory tract diseases--new standards in therapy].
    Ulmer WT
    Fortschr Med; 1992 Nov; 110(32):595-8. PubMed ID: 1478597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.